1,25-Dihydroxyvitamin D3-Induced Genes in Osteoblasts

Total Page:16

File Type:pdf, Size:1020Kb

1,25-Dihydroxyvitamin D3-Induced Genes in Osteoblasts 1,25-DIHYDROXYVITAMIN D3-INDUCED GENES IN OSTEOBLASTS: UNCOVERING NEW FUNCTIONS FOR MENINGIOMA 1 AND SEMAPHORIN 3B IN SKELETAL PHYSIOLOGY by XIAOXUE ZHANG Submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Thesis advisor: Paul N. MacDonald Department of Pharmacology CASE WESTERN RESERVE UNIVERSITY May 2009 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of _____________________________________________________ candidate for the ______________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. I dedicate this thesis to my mother and father for their lifelong love, encouragement and sacrifice TABLE OF CONTENTS Table of Contents ii List of Tables iii List of Figures iv Acknowledgements vii Abbreviations x Abstract xiii Chapter I Introduction 1 Chapter II Meningioma 1 (MN1) is a 1,25-dihydroxyvitamin D3- 44 induced transcription coactivator that promotes osteoblast proliferation, motility, differentiation, and function Chapter III Semaphorin 3B (SEMA3B) is a 1,25- 108 dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice Chapter IV Summary and future directions 155 Reference List 175 ii LIST OF TABLES Table II-1 Amplification primers used to generate cDNA probes for 77 Northern blot analysis iii LIST OF FIGURES Figure I-1 The metabolism of vitamin D 32 Figure I-2 The structure and activation of VDR 34 Figure I-3 The model of VDR mediated transcription 36 Figure I-4 The scheme of bone remodeling 38 Figure I-5 MN1 knockout mice have severe defects in cranial skeletal 40 development Figure I-6 The scheme of vertebrate semaphorins and SEMA3B 42 signaling Figure II-1 1,25(OH)2D3 induces MN1 expression in MG-63 78 osteoblastic cells Figure II-2 The mechanism of MN1 regulation in MG-63 cells 80 Figure II-3 MN1 mRNA transcripts are induced by 1,25(OH)2D3 and 82 by osteoblastic cell differentiation Figure II-4 MN1 augments 1,25(OH)2D3/VDR mediated transcription 84 Figure II-5 MN1 shows selectivity on coactivating nuclear receptors 86 Figure II-6 MN1 cooperates with SRC coactivators to stimulate VDR- 88 mediated transcription Figure II-7 MN1 knockout osteoblasts have diminished VDR-mediated 90 transcriptional responses Figure II-8 MN1 knockout osteoblasts have reduced growth rate in 92 vitro Figure II-9 MN1 knockout calvarial cells have reduced proliferation in 94 vivo iv Figure II-10 MN1 knockout osteoblasts have altered morphology and 96 reduced motility Figure II-11 MN1 knockout osteoblasts have reduced alkaline 98 phosphatase activity Figure II-12 MN1 knockout osteoblasts show decreased mineralization 100 Figure II-13 MN1 knockout osteoblasts show enhanced adipogenesis 102 Figure II-14 MN1 knockout osteoblasts have reduced ability to support 104 1,25(OH)2D3-stimulated osteoclastogenesis Figure II-15 MN1 stimulates RANKL promoter activity 106 Figure III-1 1,25(OH)2D3 induces SEMA3B expression in MG-63 133 osteoblastic cells Figure III-2 The mechanism of SEMA3B regulation in MG-63 cells 135 Figure III-3 SEMA3B is induced by 1,25(OH)2D3 and by osteoblastic 137 differentiation in ST-2 bone marrow stromal cells Figure III-4 SEMA3B is induced by 1,25(OH)2D3 and by differentiation 139 in MC3T3-E1 cells and primary osteoblasts Figure III-5 SEMA3B is expressed in the long bones of mice 141 Figure III-6 Transgenic mice with targeted osteoblast-selective 143 expression of SEMA3B have reduced body weight and shorter bones Figure III-7 SEMA3B-expressing transgenic mice have decreased 145 bone mineral density and diminished trabecular bone Figure III-8 Transgenic bones have normal osteoblasts but increased 147 osteoclastogenesis Figure III-9 SEMA3B transgenic osteoblasts have increased ability to 149 support 1,25(OH)2D3-stimulated osteoclastogenesis v Figure III-10 SEMA3B transgenic osteoblasts have increased ability to 151 support 1,25(OH)2D3-stimulated osteoclastogenesis Figure III-11 SEMA3B promotes osteoclast differentiation in RAW 264.7 153 cells vi Acknowledgements I would like to acknowledge my advisor, Dr. Paul MacDonald, for the continuous support and encouragement during the graduate study. Being patient and knowledgeable, he gave me step-by-step instruction and guidance on science. I would like to thank Dr. Diane Dowd, our lab member and my thesis committee member, who provided a lot of expertise on experiments and assistance on scientific writing. I would like to acknowledge my thesis committee members, Dr. Ruth Keri, Dr. David Danielpour, and Dr. Yu-Chung Yang, for their valuable inputs on my projects, especially when I was in difficult times and needed discussions and suggestions. I would like to thank my previous and current lab members for their help on experiments, classes, and presentation practice. Dr. Amelia Sutton identified MN1 and SEMA3B and started excellent studies about these two genes. She generated SEMA3B transgenic animals, performed bone imaging analysis, and set up protocols for animal handling and bone cell analysis. Ms. Meika Moore gave plenty of assistance on animal experiments, including the maintenance, breeding, and genotyping of experimental mice. Dr. Tara Ellison made nuclear receptor expression constructs, gave valuable suggestions on molecular biology, and provided useful discussions on troubleshooting. Dr. Chi Zhang taught me a lot about graduate studies and assisted me to settle down in Cleveland. I am also grateful to other laboratories for generously sharing various equipments and vii providing valuable experimental instructions, especially to the laboratories of Drs. Ruth Keri, Ruth Siegel, Monica Montano, and Yu-Chung Yang. I would like to acknowledge the previous and current departmental members, including Dr. Erin Milliken, Dr. Yu Chen, Dr. Hui Wang, Dr. Yiping Rong, Dr. Gang Zheng, for their help on classes, experiments, presentations, preliminary exams, and career choice. I would also like to thank the Pharmacology Department for providing this great training program. I would like to acknowledge Dr. Ellen C. Zwarthoff (Erasmus Medical Center, Rotterdam, The Netherlands) and Dr. Gerard Grosveld (St. Jude Children’s Research Hospital, Memphis, TN) for providing MN1 knockout mice breeding pairs. I would also like to thank Dr. Benoit de Crombrugghe for providing the 2300lacZ plasmid, Dr. John D. Minna for providing the pcDNA3- SEMA3B plasmid, Dr. Edward Greenfield for the assistance with in vitro osteoblast and osteoclast assays, and Ms. Patty Lott and the staff at the University of Alabama at Birmingham, Center for Metabolic Bone Disease, Histomorphometry and Molecular Analysis Core Laboratory, for performing the mineralized bone histology and histomorphometry. Finally, I would like to acknowledge Dr. Bernard Tandler for helping me edit the thesis. I would like to thank my undergraduate teacher, Dr. Zihe Rao, for his continuous care and unconditional support during the past ten years. I would like to thank all the friends in my everyday life. It is their care and encouragement that made me able to accomplish the study abroad. I would like viii to thank all my family members, who are so far away, but trying their best to support me to finish my graduate study. ix Abbreviations 1,25(OH)2D3 1,25-dihydroxyvitamin D3 1α-hydroxylase 25-hydroxyvitamin D-1α-hydroxylase 24-hydroxylase 25-hydroxyvitamin D3-24-hydroxylase 25-hydroxylase vitamin D 25-hydroxylase 25(OH)D3 25-hydroxycholecalciferol 9-cis RA 9-cis retinoic acid AF-2 Activation function-2 ALP Alkaline phosphatase AML Acute myeloid leukemia ATP Adenosine triphosphate ATRA All trans retinoic acid BCA Bicinchoninic acid BMP Bone morphogenetic protein BrdU 5-bromo-2-deoxyuridine C/EBP CCAAT/enhancer-binding protein cAMP Cyclic adenosine monophosphate CaSR Calcium-sensing receptor Cbfa Core binding factor CBP CREB-binding protein CBS Bovine calf serum CCD Cleidocranial dysplasia CDK Cyclin dependent kinase CDKI CDK inhibitor CM Conditional media CT Computed tomography CREB cAMP response element binding protein CTD carboxyl terminal domain DAPI 4',6-diamidino-2-phenylindole DBD DNA-binding domain DEXA Dual-energy X-ray absorptiometry Dlx Distal-less homeobox DNA Deoxyribonucleic acid DR Direct repeats DRIP Vitamin D receptor interacting protein E2 17β-estradiol EGFR Epidermal growth factor receptor EMSA Electrophoretic mobility shift assay ER Estrogen receptor FABP4 Fatty acid binding protein 4 FBS Fetal bovine serum FGF Fibroblast growth factor FRP-4 Fizzled-related protein 4 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GDF Growth/differentiation factor x GR Glucocorticoid receptor GRE Glucocorticoid response element GRIP Glucocorticoid receptor interacting protein HAT Histone acetyltransferase HC Hypertrophic chondrocyte zone HDAC Histone deacetylase Hr Hairless IGF Insulin-like growth factor IGFBP IGF binding protein Ihh Indian hedgehog IL Interleukin KO Knockout LBD Ligand-binding domain LOH Loss of heterozygosity LPL Lipoprotein lipase LRP Low-density lipoprotein receptor-related protein MAP Mitogen-activated protein MAR Mineral apposition rate MARRS Membrane-associated, rapid
Recommended publications
  • Suitability of Immobilized Systems for Microbiological Degradation of Endocrine Disrupting Compounds
    molecules Review Suitability of Immobilized Systems for Microbiological Degradation of Endocrine Disrupting Compounds Danuta Wojcieszy ´nska , Ariel Marchlewicz and Urszula Guzik * Institute of Biology, Biotechnology and Environmental Protection, Faculty of Natural Science, University of Silesia in Katowice, Jagiello´nska28, 40-032 Katowice, Poland; danuta.wojcieszynska@us.edu.pl (D.W.); ariel.marchlewicz@us.edu.pl (A.M.) * Correspondence: urszula.guzik@us.edu.pl; Tel.: +48-3220-095-67 Academic Editors: Urszula Guzik and Danuta Wojcieszy´nska Received: 10 September 2020; Accepted: 25 September 2020; Published: 29 September 2020 Abstract: The rising pollution of the environment with endocrine disrupting compounds has increased interest in searching for new, effective bioremediation methods. Particular attention is paid to the search for microorganisms with high degradation potential and the possibility of their use in the degradation of endocrine disrupting compounds. Increasingly, immobilized microorganisms or enzymes are used in biodegradation systems. This review presents the main sources of endocrine disrupting compounds and identifies the risks associated with their presence in the environment. The main pathways of degradation of these compounds by microorganisms are also presented. The last part is devoted to an overview of the immobilization methods used for the purposes of enabling the use of biocatalysts in environmental bioremediation. Keywords: EDCs; hormones; degradation; immobilization; microorganisms 1. Introduction The development of modern tools for the separation and identification of chemical substances has drawn attention to the so-called micropollution of the environment. Many of these contaminants belong to the emergent pollutants class. According to the Stockholm Convention they are characterized by high persistence, are transported over long distances in the environment through water, accumulate in the tissue of living organisms and can adversely affect them [1].
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD (cevansmo@iu.edu) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • On the Turning of Xenopus Retinal Axons Induced by Ephrin-A5
    Development 130, 1635-1643 1635 © 2003 The Company of Biologists Ltd doi:10.1242/dev.00386 On the turning of Xenopus retinal axons induced by ephrin-A5 Christine Weinl1, Uwe Drescher2,*, Susanne Lang1, Friedrich Bonhoeffer1 and Jürgen Löschinger1 1Max-Planck-Institute for Developmental Biology, Spemannstrasse 35, 72076 Tübingen, Germany 2MRC Centre for Developmental Neurobiology, King’s College London, New Hunt’s House, Guy’s Hospital Campus, London SE1 1UL, UK *Author for correspondence (e-mail: uwe.drescher@kcl.ac.uk) Accepted 13 January 2003 SUMMARY The Eph family of receptor tyrosine kinases and their turning or growth cone collapse when confronted with ligands, the ephrins, play important roles during ephrin-A5-Fc bound to beads. However, when added in development of the nervous system. Frequently they exert soluble form to the medium, ephrin-A5 induces growth their functions through a repellent mechanism, so that, for cone collapse, comparable to data from chick. example, an axon expressing an Eph receptor does not The analysis of growth cone behaviour in a gradient of invade a territory in which an ephrin is expressed. Eph soluble ephrin-A5 in the ‘turning assay’ revealed a receptor activation requires membrane-associated ligands. substratum-dependent reaction of Xenopus retinal axons. This feature discriminates ephrins from other molecules On fibronectin, we observed a repulsive response, with the sculpturing the nervous system such as netrins, slits and turning of growth cones away from higher concentrations class 3 semaphorins, which are secreted molecules. While of ephrin-A5. On laminin, retinal axons turned towards the ability of secreted molecules to guide axons, i.e.
    [Show full text]
  • Benefits of Cancerplex
    CancerPlexSM is a comprehensive genetic assessment of a patient’s tumor that guides oncologists towards effective treatment options. What is CancerPlex? CancerPlex is a next generation DNA sequencing test for solid SM tumors. The specific coding regions of over 400 known cancer Potential outcomes from CancerPlex genes are simultaneously determined using a small amount of Identification of variants associated with response or resis- DNA extracted from tumor samples, including formalin-fixed, tance to an FDA-approved therapy for the patient’s disease. paraffin-embedded (FFPE) tissue and cell blocks from fine-needle aspirates or effusions. This analysis is performed in a single assay, Identification of variants associated with response or resis- simplifying and streamlining the test ordering process, and eliminat- tance to a therapy associated with another clinical indication. ing time consuming serial testing. Clinically actionable information unique to each patient’s tumor is consolidated into a simple report. Identification of variants associated with a therapy(s) in CancerPlex reveals missense changes, insertions and deletions, clinical development. and previously described rearrangements of ALK, RET, and ROS. Benefits of CancerPlex: CancerPlex genes were selected because of their importance in tumor The average turn-around-time for CancerPlex is under 10 biology. Analyzing more genes increases the chance of discovering business days, dramatically shortening the waiting period for actionable findings that lead to more choices for treatment. Our initial the start of treatment. results indicate that CancerPlex analysis identifies actionable findings up to 20% more frequently than previously published studies. CancerPlex ordering is simple: KEW provides all necessary shipping materials, can facilitate tissue retrieval and return with Since knowledge of tumor biology changes rapidly, CancerPlex pathologists, and manages 3rd party payment for the test.
    [Show full text]
  • Endothelin-2 Signaling in the Neural Retina Promotes the Endothelial Tip Cell State and Inhibits Angiogenesis
    Endothelin-2 signaling in the neural retina promotes PNAS PLUS the endothelial tip cell state and inhibits angiogenesis Amir Rattnera,1, Huimin Yua, John Williamsa,b, Philip M. Smallwooda,b, and Jeremy Nathansa,b,c,d,1 Departments of aMolecular Biology and Genetics, cNeuroscience, and dOphthalmology and bHoward Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205 Contributed by Jeremy Nathans, August 20, 2013 (sent for review February 19, 2013) Endothelin signaling is required for neural crest migration and time lapse imaging studies of vascular development in zebrafish homeostatic regulation of blood pressure. Here, we report that and mammalian EC dynamics in explant culture show that the tip constitutive overexpression of Endothelin-2 (Edn2) in the mouse cell and stalk cell states are highly plastic, with frequent retina perturbs vascular development by inhibiting endothelial cell exchanges between the two cell states (8, 9). migration across the retinal surface and subsequent endothelial Several other signaling pathways are also essential for retinal cell invasion into the retina. Developing endothelial cells exist in vascular development. Norrin, a Muller-glia–derived ligand, and one of two states: tip cells at the growing front and stalk cells in its EC receptor Frizzled4 (Fz4), coreceptor Lrp5, and receptor the vascular plexus behind the front. This division of endothelial chaperone Tspan12 activate canonical Wnt signaling in de- cell states is one of the central organizing principles of angiogen- veloping ECs (10). In humans and mice, defects in any of these esis. In the developing retina, Edn2 overexpression leads to components lead to retinal hypovascularization.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Part I Biopharmaceuticals
    1 Part I Biopharmaceuticals Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 3 1 Analogs and Antagonists of Male Sex Hormones Robert W. Brueggemeier The Ohio State University, Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Columbus, Ohio 43210, USA 1Introduction6 2 Historical 6 3 Endogenous Male Sex Hormones 7 3.1 Occurrence and Physiological Roles 7 3.2 Biosynthesis 8 3.3 Absorption and Distribution 12 3.4 Metabolism 13 3.4.1 Reductive Metabolism 14 3.4.2 Oxidative Metabolism 17 3.5 Mechanism of Action 19 4 Synthetic Androgens 24 4.1 Current Drugs on the Market 24 4.2 Therapeutic Uses and Bioassays 25 4.3 Structure–Activity Relationships for Steroidal Androgens 26 4.3.1 Early Modifications 26 4.3.2 Methylated Derivatives 26 4.3.3 Ester Derivatives 27 4.3.4 Halo Derivatives 27 4.3.5 Other Androgen Derivatives 28 4.3.6 Summary of Structure–Activity Relationships of Steroidal Androgens 28 4.4 Nonsteroidal Androgens, Selective Androgen Receptor Modulators (SARMs) 30 4.5 Absorption, Distribution, and Metabolism 31 4.6 Toxicities 32 Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 4 Analogs and Antagonists of Male Sex Hormones 5 Anabolic Agents 32 5.1 Current Drugs on the Market 32 5.2 Therapeutic Uses and Bioassays
    [Show full text]
  • Evolution of the Bile Salt Nuclear Receptor FXR in Vertebrates
    Supplemental Material can be found at: http://www.jlr.org/cgi/content/full/M800138-JLR200/DC1 Evolution of the bile salt nuclear receptor FXR in vertebrates † † † †† †† Erica J. Reschly,* Ni Ai, Sean Ekins, ,§,** William J. Welsh, Lee R. Hagey, Alan F. Hofmann, and Matthew D. Krasowski1,* † Department of Pathology,* University of Pittsburgh, Pittsburgh, PA 15261; Department of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ 08854; Collaborations in Chemistry,§ Jenkintown, PA 19046; Department of Pharmaceutical Sciences,** †† University of Maryland, Baltimore, MD 21202; and Department of Medicine, University of California-San Diego, San Diego, CA 92093-0063 Abstract Bile salts, the major end metabolites of cho- Bile salts are water-soluble, amphipathic end metabolites lesterol, vary significantly in structure across vertebrate of cholesterol that facilitate intestinal absorption of lipids species, suggesting that nuclear receptors binding these (1), enhance proteolytic cleavage of dietary proteins (2), Downloaded from molecules may show adaptive evolutionary changes. We com- and have potent antimicrobial activity in the small intestine pared across species the bile salt specificity of the major (3). In addition, bile salt signaling via nuclear hormone re- transcriptional regulator of bile salt synthesis, the farnesoid X receptor (FXR). We found that FXRs have changed speci- ceptors (NHRs) is important for bile salt homeostasis (4). ficity for primary bile salts across species by altering the Bile salts have not been detected in invertebrate animals. shape and size of the ligand binding pocket. In particular, In contrast to steroid hormones and vitamins, whose struc- the ligand binding pockets of sea lamprey (Petromyzon marinus) tures tend to be strongly conserved, bile salts exhibit www.jlr.org and zebrafish (Danio rerio) FXRs, as predicted by homology marked structural diversity across species (5–7).
    [Show full text]
  • Intrinsically Disordered Meningioma-1 Stabilizes the BAF Complex to Cause AML
    Article Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML Graphical abstract Authors Simone S. Riedel, Congcong Lu, Hongbo M. Xie, ..., Gerd A. Blobel, Benjamin A. Garcia, Kathrin M. Bernt Correspondence berntk@chop.edu In brief Meningioma-1 (MN1) translocations result in overexpression of MN1 through enhancer hijacking, or expression of an MN1 fusion protein. MN1 is an intrinsically disordered polyQ protein. MN1 overexpression is sufficient to cause malignant transformation via over- stabilization of the BAF complex at critical enhancers. Highlights d MN1 translocations in AML result in MN1 overexpression due to enhancer hijacking d MN1 interacts with the myeloid progenitor BAF complex d MN1 over-stabilizes the BAF complex at critical enhancers d Overexpression of the polyQ protein MN1 is sufficient to cause AML Riedel et al., 2021, Molecular Cell 81, 1–17 June 3, 2021 ª 2021 Elsevier Inc. https://doi.org/10.1016/j.molcel.2021.04.014 ll Please cite this article in press as: Riedel et al., Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML, Molecular Cell (2021), https://doi.org/10.1016/j.molcel.2021.04.014 ll Article Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML Simone S. Riedel,1 Congcong Lu,2 Hongbo M. Xie,3 Kevin Nestler,1 Marit W. Vermunt,4 Alexandra Lenard,1 Laura Bennett,5 Nancy A. Speck,5 Ichiro Hanamura,6 Julie A. Lessard,7 Gerd A. Blobel,4,8 Benjamin A. Garcia,2 and Kathrin M. Bernt1,8,9,* 1Division of Pediatric Oncology, Children’s Hospital
    [Show full text]
  • Immuno 2014 No. 1
    Journal of Blood Group Serology and Molecular Genetics VOLUME 30, N UMBER 1, 2014 Immunohematology Journal of Blood Group Serology and Molecular Genetics Volume 30, Number 1, 2014 CONTENTS R EPORT 1 Indirect antiglobulin test-crossmatch using low-ionic-strength saline–albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization C.L. Dinardo, S.L. Bonifácio, and A. Mendrone, Jr. R EV I EW 6 Raph blood group system M. Hayes R EPORT 11 I-int phenotype among three individuals of a Parsi community from Mumbai, India S.R. Joshi C A SE R EPORT 14 Evans syndrome in a pediatric liver transplant recipient with an autoantibody with apparent specificity for the KEL4 (Kpb) antigen S.A. Koepsell, K. Burright-Hittner, and J.D. Landmark R EV I EW 18 JMH blood group system: a review S.T. Johnson R EPORT 24 Demonstration of IgG subclass (IgG1 and IgG3) in patients with positive direct antiglobulin tests A. Singh, A. Solanki, and R. Chaudhary I N M EMOR ia M 28 George Garratty, 1935–2014 Patricia A. Arndt and Regina M. Leger 30 A NNOUNCEMENTS 34 A DVERT I SEMENTS 39 I NSTRUCT I ONS FOR A UTHORS E D I TOR - I N -C H I EF E D I TOR ia L B OA RD Sandra Nance, MS, MT(ASCP)SBB Philadelphia, Pennsylvania Patricia Arndt, MT(ASCP)SBB Paul M. Ness, MD Pomona, California Baltimore, Maryland M A N AG I NG E D I TOR James P.
    [Show full text]
  • Mir-146A Regulates Migration and Invasion by Targeting NRP2 in Circulating-Tumor Cell Mimicking Suspension Cells
    G C A T T A C G G C A T genes Article MiR-146a Regulates Migration and Invasion by Targeting NRP2 in Circulating-Tumor Cell Mimicking Suspension Cells Yeojin Do 1, Jin Gu Cho 1, Ji Young Park 1, Sumin Oh 1, Doyeon Park 1 , Kyung Hyun Yoo 1,2 , Myeong-Sok Lee 1,2, Byung Su Kwon 3,* , Jongmin Kim 1,2,* and Young Yang 2,* 1 Division of Biological Sciences, Sookmyung Women’s University, Seoul 04310, Korea; yeojin0764@sookmyung.ac.kr (Y.D.); jgcho84@sookmyung.ac.kr (J.G.C.); pakgy1018@sookmyung.ac.kr (J.Y.P.); soh@sookmyung.ac.kr (S.O.); pdy1748@sookmyung.ac.kr (D.P.); khryu@sookmyung.ac.kr (K.H.Y.); mslee@sookmyung.ac.kr (M.-S.L.) 2 Research Institute for Women’s Health, Sookmyung Women’s University, Seoul 04310, Korea 3 Department of Obstetrics and Gynecology, Kyung Hee University Medical Center, 23, Seoul 02447, Korea * Correspondence: kbsgyonco@naver.com (B.S.K.); jkim@sookmyung.ac.kr (J.K.); yyang@sookmyung.ac.kr (Y.Y.); Tel.: +82-2-958-8837 (B.S.K.); +82-2-710-9553 (J.K.); +82-2-710-9590 (Y.Y.) Abstract: Cancer metastasis is the primary cause of cancer-related death and metastatic cancer has circulating-tumor cells (CTCs), which circulate in the bloodstream before invading other organs. Thus, understanding the precise role of CTCs may provide new insights into the metastasis process and reduce cancer mortality. However, the molecular characteristics of CTCs are not well understood due to a lack of number of CTCs.
    [Show full text]